IL1B and Alzheimer disease: The same was observed in this study, in which IL-1α and IL-1β levels were low/undetectable in healthy controls, and also in patients with SMC and MCI, with the exception of AD patients who showed a small but statistically significant increase in the levels of both cytokines.